Bacterin, Zimmer, SpineGuard & more — 19 key notes

Written by Anuja Vaidya | April 10, 2015 | Print  |

Here are 19 key notes on spine and orthopedic device companies.

Atlas Spine plans to raise money through OfferBoard Securities in Series B financing.


 
Bacterin unveiled the preliminary fist quarter 2015 financial results — Total net revenue was $9.4 million to $9.5 million.

 

Bacterin also received a United States patent for technology included in the company's OsteoSponge products.

 

Additionally, Bacterin stock will be trading on the OTCQX marketplace after the New York Stock Exchange suspended trading the company's common stock.

 

Results from the KAST trial, involving Benvenue Medical's Kiva VCF Treatment System and its efficacy as compared to balloon kyphoplasty, have been published in Spine.


 
DJO global appointed Jeanine Kestler as the new executive vice president and chief human resources officer.

 

Instratek announced the United States launch of its STAPiX Superelastic Nitinol Staple Fixation System.

 

Integra LifeScience had their consensus rating updated to "buy" from seven brokerages.


 
K2M shares reached $23.89 on April 7, which a new 52-week high for the company.

 

Mazor reported three new Renaissance system orders in the first quarter of 2015.


 
Elos entered into an agreement to acquire Onyx Medical.


 
Zacks updated Orthofix's price target to $36.

 

Osiris Therapeutics named Alla Danilkovitch, PhD, chief scientific officer.

 

Safe Orthopaedics announced the European launch of its new fenestrated screw.


 
Spine Pain Management wasissued a "notice of allowance," allowing all claims, by the U.S. Patent and Trademark Office for its Quad Video HALO.

 

SpineGuard released their first quarter 2015 financial report, and United States revenue was up 59 percent, while revenue from the rest of the world was up 20 percent.

 

Barclays downgraded Stryker shares, and they currently have an "underweight" rating, down from "equal weight."

 

Titan Spine announced that data from an award-winning study comparing its proprietary surface technology to polyetheretherketone was published in Spine.

 

Zimmer is initiating a voluntary recall of Persona Trabecular Metal Tibia.

 

More articles on orthopedic devices:
Spine device stock report: 5 key companies
New devices & techniques: Which spine surgery innovations are most exciting for surgeons?
DJO Global names Jeanine Kestler EVP, chief HR officer

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months